. 2018 Jul 17;144(10):2001–2010. doi: 10.1007/s00432-018-2688-3
© The Author(s) 2018
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Table 3.
Primary efficacy parameters: PFS and OS for RAS Positive
